News - Rxlogix - Page 2 News - Rxlogix - Page 2

Search results for:

Large pharma goes live with FDA IND E2B(R3) ahead of schedule

EMA successfully goes live with RxLogix Safety Surveillance Suite.

The world’s largest generic pharmaceutical company, with a portfolio of over 3,000 products, has gone live with RxLogix PV Signal and PV Analytics

A Top 25 global biotechnology company goes live with PV Reports Japan.

The client is already in production with PV Reports, PV Central and PV DataHub for several years. Project included end-to-end implementation of PV Reports Japan solution. The project complexity was high as migrated Japanese case data needed to be augmented in an existing global PV Datahub. The project was executed successfully.

A large, rare disease global biopharmaceutical company that is dedicated to finding solutions to help patients living with rare diseases implements additional RxLogix PV systems

It was a large project that included the following key systems and capabilities: PV Quality – New system implementation to monitor the PV case quality PV Reports Upgrade Implementation of Reporting Rate calculations in disproportionality algorithms based on imported drug sales/patient exposure data EVDAS auto-download utility PV Reports Japan – Two new reports (NUPR, SLL) […]